QA: TENAX THERAPEUTICS INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000034956_2023_TENAX_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000034956, TENAX THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 3,208,465
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 7,189
3 remainder_Assets 189,055
4 LiabilitiesCurrent 1,847,772
5 LiabilitiesNoncurrent 64,196
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,675,231
9 ResearchAndDevelopmentExpense 5,377,412
10 remainder_Expenses 4,443
11 remainder_Revenues 9,191
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 3,404,709
1 Liabilities 1,911,968
2 Expenses 11,057,086
3 Revenues 9,191
4 StockholdersEquity 1,492,741
5 NetIncome -11,047,895
6 ComprehensiveNetIncome -11,047,895
7 BaseVar 8,191,477
8 EconomicCapitalRatio -3.19

Edgar->Model Mapping

Feature Distribution

Change over Time